Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (6337)	1/18/1999 2:47:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 9719

Quick question...anybody know if there was anything said at H&Q regarding Lisofylline? The ctic thread has been pretty quiet here on SI...the last thing I saw was in a press release a month ago. He underscored that important imbalances in risk factors between the placebo and lisofylline groups may have resulted in the failure to achieve a significant effect on the study's primary endpoints of infection and mortality. biz.yahoo.com Does anybody know anything from the BCHE presentation? I think both Cell Therapeutics and BioChem Pharma were there, but neither bothered to put out a press release about the event. here is the url for the recap trial's graphic recap.com and ctic's website...which has no new information that I can find. cticseattle.com --Mike